Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**STYLAGE M + lidocaine** is a combination cosmetic formulation consisting of cross-linked hyaluronic acid (20 mg/ml), lidocaine (0.3%), and antioxidants such as mannitol and sorbitol. It is developed to correct medium to deep facial wrinkles and folds, including nasolabial folds and marionette lines, and is suitable for enhancing lip contours, hand rejuvenation, and subtle facial volume restoration (cheeks, temples, chin). Lidocaine minimizes pain during injection; mannitol and sorbitol act as antioxidants, protecting hyaluronic acid from degradation and reducing inflammation and swelling. The filler is injected into the deep layer of the dermis, providing immediate, long-lasting effects and improved skin hydration and elasticity. Developed and manufactured by Vivacy, this product is widely used by medical professionals for non-surgical aesthetic indications[1][2][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on STYLAGE M + lidocaine.